Board Appointment

Advanced Medical Solutions Grp PLC
11 April 2006


For immediate release                                              11 April 2006


                      Advanced Medical Solutions Group plc
                            ('AMS' or 'the Company')

                               Board Appointment


Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global
medical technology company, today announces that Mr. Andrew Christopher Meredith
has been appointed to the Board as an Executive Director.

Mr. Meredith, age 39, joined AMS in July 2005 as Group Commercial Director with
the objective of integrating sales, marketing, customer services and business
development across the Company.  He formerly held senior commercial roles within
Europe with Banner Pharmacaps Inc. and Cardinal Health Inc. and gained medical
device experience with Smiths Group plc.

This realignment has been completed and the commercial resources organised in
line with the Company's market and partner focus.  New Business Development VPs
have been appointed to support European and US customers for the Company's
branded partner business and the UK sales team has been strengthened behind the
Company's LiquiBandTM wound closure adhesive and ActivHeal(R) advanced woundcare
range, which are sold directly into the NHS.

Mr Meredith has an interest in 500,000 shares in the Company allocated to him
under the Company's Long Term Incentive Plan. These were granted on 12 October
2005. There are no other matters which are required to be announced with regards
to this appointment under paragraph (g) of Schedule 2 of the AIM Rules.

Commenting on this announcement Dr. Geoffrey N. Vernon, Non-Executive Chairman
of AMS, stated:

'Since joining AMS, Chris has made a major contribution to the continued
successful commercialisation of the Company's technologies.  His appointment to
the Board underlines the Board's confidence in his ability to continue to drive
the Company's  future revenue and earnings growth.'



For further information, please contact:

Advanced Medical Solutions Group plc                   Tel : [phone]
Don Evans, Chief Executive
Mary Tavener, Finance Director
www.admedsol.com

Buchanan Communications                                Tel: [phone]
Mark Court, Mary-Jane Johnson



Notes to Editors:

Advanced Medical Solutions is a leading company in the development and
manufacture of products for the $13 billion global woundcare market.

Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions is
focused on the design, development and manufacture of innovative and
technologically advanced products for woundcare and other medical applications.

In-house natural and synthetic polymer technology is used to provide advanced
wound dressings based on the moist healing principle. AMS' resources ensure a
unique position as a vertically integrated 'one stop shop' to provide all
categories of moist wound healing products. The Company has the capability to
move from product design and development through to production and delivery
ready for distribution into customer markets.

The acquisition of MedLogic in 2002 has brought AMS products and technology in
cyanoacrylate based tissue adhesives that offer benefits over sutures and
staples for closing wounds sold direct to hospitals or through distributors.

AMS' technology and products currently serve the majority of the key global
markets and strategic partners.


                      This information is provided by RNS
            The company news service from the London Stock Exchange